RETRACTED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated DatabaseArticle Published on 2022-03-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 치료법, [키워드] Abstract approved article association authors clinical evidence Clinical practice clinical trials conducted confounding variables COVID COVID-19 COVID-19 mortality Decreased effective Efficacy eight Elsevier evaluate FDA General population gold standard Hypothesis Ivermectin limitation medication patients treated Physicians Policy public health randomized clinical trial reduce reduction in mortality Remdesivir Retrospective study Scientific community Severity of disease the patient Treatment [DOI] 10.1016/j.ijid.2021.12.096 [Article Type] Article
Does ivermectin have a place in the treatment of mild Covid-19?Editorial Published on 2022-03-012022-10-05 Journal: New Microbes and New Infections [Category] 신약개발, 치료법, [키워드] Coronavirus treatment Hospitalization Ivermectin Mild molnupiravir Paxlovid SARS-CoV-2 Treatment [DOI] 10.1016/j.nmni.2022.100985 [Article Type] Editorial
Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis스트롱길로이드증의 유병률이 높은 지역과 낮은 지역 간의 COVID-19에 Ivermectin을 사용한 시험의 비교: 메타 분석Meta-Analysis Published on 2022-03-012022-09-11 Journal: JAMA Network Open [Category] 임상, 치료제, [키워드] 95% CI Analysis association Characteristics claimed clinical trial clinical trials correlation coefficient COVID-19 data extraction database decrease difference effect sizes effective Endemic estimate evaluate Evidence explained group heterogeneity Hypothesis increase in interact Interaction Interpretation item Ivermectin Meta-analysis meta-regression Mortality original outcome Patient patients patients with COVID-19 Prevalence random-effect Random-effects meta-analysis randomization randomized clinical trial randomized clinical trials Region Relative risk Reporting review risk RR of mortality significant difference significantly statistically significant strongyloidiasis synthesis systematic reviews Testing took place Treatment treatment for COVID-19 Trial Variability variance were excluded [DOI] 10.1001/jamanetworkopen.2022.3079 PMC 바로가기 [Article Type] Meta-Analysis
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2렘데시비르-이버멕틴 조합은 SARS-CoV-2에 대한 개선된 시험관 내 활성과 상승적인 상호작용을 나타냅니다Article Published on 2022-03-012022-09-11 Journal: International journal of antimicrobial agents [Category] SARS, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 antiviral activity approved Combination combination therapy combination treatment coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 CPE Cytopathic activity demonstrated drug Drug administration drug resistance effective Efficacy food greater in vitro in vitro activity in vivo Interaction Ivermectin management mechanism offer reduce Remdesivir reported SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Support synergistic synergistic action synergy therapeutic therapeutic index to define Treatment strategies US Food and Drug Administration [DOI] 10.1016/j.ijantimicag.2022.106542 PMC 바로가기 [Article Type] Article
Comparison of the Ivermectin and Lopinavir/Ritonavir Treatment Outcomes among COVID-19 Mild to Moderate Cases in Kaduna StateComparative Study Published on 2022-02-282023-07-08 Journal: West African journal of medicine [Category] COVID19(2023년), [키워드] Alluvia clinical trial COVID-19 Ivermectin MRT Treatment [Article Type] Comparative Study
Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 PatientsPublic Health Published on 2022-02-222022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, COVID19(2023년), SARS, [키워드] absence administration Admission adverse event adverse events Analysis Antiviral assessment carried clinical utility Control controls COVID-19 COVID-19 patients drug Efficacy Emergency use experimental intervention High dose High-dose highlight ICU ICU admission ICU-admission intensive care unit intention to treat Intervention Ivermectin ivermectin group Laboratory Ministry of Health Mortality Odds ratio offered participant patients performed Program reported Research Result Safety safety profile SARS-CoV-2 significantly lower Standard of care subject subjects subset symptoms onset was performed WHO with COVID-19 [DOI] 10.3389/fpubh.2022.813378 PMC 바로가기 [Article Type] Public Health
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patientsShort Communication Published on 2022-02-092022-10-31 Journal: Future Microbiology [Category] COVID-19, COVID19(2023년), SARS, [키워드] Administered average CDC clinical clinical observations Combination combination therapy controlled trials controls coronavirus COVID COVID-19 COVID-19 patient database deaths doxycycline effective Features Helicobacter pylori Hospitalization hypoxia hypoxic Ivermectin less moderate Outpatient oxygen saturation random resolved Result Safe SARS-CoV-2 subject Symptom Symptoms therapeutic therapy Treatment Vitamin Zinc [DOI] 10.2217/fmb-2022-0014 PMC 바로가기 [Article Type] Short Communication
Intravenous veterinary ivermectin in a COVID-19 patient causing neurotoxicityCase report Published on 2022-02-072022-10-05 Journal: IDCases [Category] 신약개발, [키워드] administration Concentration Confirmed COVID-19 infection Coronavirus disease 2019 COVID-19 COVID-19 patient dose Hospitalization ICU Infection intensive care intravenous Ivermectin neurotoxicity occur Parenteral Patient required safety profile Serious Adverse Event serum subcutaneous injection was determined [DOI] 10.1016/j.idcr.2022.e01446 [Article Type] Case report
Repurposing the drug, ivermectin, in COVID-19: toxicological points of viewCovid-19에서 약물, Ivermectin의 용도 : 독성 관점Review Published on 2022-02-052022-08-31 Journal: European Journal of Medical Research [Category] 신약개발, 임상, 치료제, [키워드] affected appear Behavior changes in clinician Colchicine Coronavirus disease 2019 COVID-19 COVID-19 pandemic dose drug effective Effectiveness evaluated except for FDA food Food and Drug Administration in vitro inhibitory activity interferon Ivermectin medication observational studies pandemic patients with COVID-19 potential therapies question repurposing Safe SARS-CoV-2 SARS-CoV-2 replication shown Side effects social distancing steroid Steroids suggested therapeutic effect Tocilizumab Treatment treatment of COVID-19 [DOI] 10.1186/s40001-022-00645-8 PMC 바로가기 [Article Type] Review
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trialCOVID-19의 조기 치료를 위한 고용량 이버멕틴(COVER 연구): 무작위, 이중 맹검, 다기관, 2상, 용량 찾기, 개념 증명 임상 시험Clinical Trial Published on 2022-02-012022-09-11 Journal: International journal of antimicrobial agents [Category] COVID19(2023년), MERS, SARS, 신약개발, 임상, 진단, 치료법, 치료제, [키워드] Adverse drug reaction Adverse drug reactions Antiviral antiviral activity assigned calculated Chloroquine phosphate CNS Concentration COVID-19 criteria Day demonstrated diagnosed dialysis double-blind early treatment Efficacy exclusion criteria High-dose Hydroxychloroquine hydroxychloroquine treatment in viral in vitro individual Ivermectin lactating log multicentre no significant difference no significant differences outcome participant Participants Placebo pregnant Primary outcomes Prognosis proof-of-concept clinical trial randomised randomised controlled trial reduce reducing Registered Safe safety analysis SARS-CoV-2 SARS-COV-2 infection significant differences Treatment Viral Viral load viral load reduction Warfarin [DOI] 10.1016/j.ijantimicag.2021.106516 PMC 바로가기 [Article Type] Clinical Trial